Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Meta Platforms Inc.

Start price
Target price
Perf. (%)
€443.80
02.02.24
-
02.02.25
0.23%
02.02.24

Probably not worthwhile Investment
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€56.70
02.02.24
€60.00
02.02.25
2.08%
03.02.24

Top 10 in its market
Well known brand
Future proof or reliable business model
EBIT growth > 30% per year expected
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.48
31.01.24
-
29.02.24
230.87%
01.03.24

buy
General Mills Inc.

Start price
Target price
Perf. (%)
€60.38
31.01.24
€62.00
31.01.25
4.01%
19.03.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
Sustainability is important
Stable Large shareholder and/or long term investor
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€3.75
29.01.24
-
29.01.25
-2.03%
03.02.24

Could be very worthwhile Investment >20% year
buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€0.99
29.01.24
€1.00
29.01.25
-49.90%
03.02.24

Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€523.50
26.01.24
€520.00
26.01.25
4.72%
16.02.24

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Lockheed Martin Corp.

Start price
Target price
Perf. (%)
€397.90
26.01.24
€380.00
26.01.25
3.69%
26.03.24

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Strong uniques
buy
RumbleON Inc.

Start price
Target price
Perf. (%)
€6.70
26.01.24
-
26.02.24
1.49%
27.02.24

Small challenges to pay loans and raise capital
Tesla Inc

Start price
Target price
Perf. (%)
€175.10
25.01.24
€160.00
29.06.25
0.67%
25.01.24

Could be very worthwhile Investment >20% year
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€0.88
25.01.24
€1.30
25.01.25
143.18%
19.02.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€76.00
25.01.24
€110.00
31.03.26
-0.66%
02.02.24

Could be very worthwhile Investment >20% year
buy
Kura Oncology Inc

Start price
Target price
Perf. (%)
€17.70
25.01.24
€16.00
31.08.25
9.60%
02.02.24

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.21
23.01.24
-
23.01.25
-15.48%
03.02.24

Probably not worthwhile Investment
buy
Colgate-Palmolive Co.

Start price
Target price
Perf. (%)
€75.00
23.01.24
€75.00
23.01.25
3.27%
30.01.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.38
22.01.24
-
22.01.25
14.50%
03.02.24

Could be very worthwhile Investment >20% year
buy
Mastercard Inc. A

Start price
Target price
Perf. (%)
€403.00
22.01.24
€406.00
22.01.25
5.91%
02.02.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Future proof or reliable business model
buy
Apple Inc.

Start price
Target price
Perf. (%)
€176.38
22.01.24
€180.00
22.01.25
-6.23%
14.04.24

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.92
22.01.24
-
22.01.25
-36.03%
03.02.24

Probably not worthwhile Investment
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.54
21.01.24
-
21.01.25
6.61%
03.02.24

Could be worthwhile Investment >10% per year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.44
21.01.24
-
21.01.25
23.55%
03.02.24

Could be worthwhile Investment >10% per year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.08
21.01.24
-
21.01.25
21.10%
03.02.24

Could be worthwhile Investment >10% per year
buy
Altimmune

Start price
Target price
Perf. (%)
€8.54
21.01.24
-
21.01.25
-0.30%
03.02.24

Could be very worthwhile Investment >20% year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€13.91
21.01.24
-
21.01.25
7.87%
03.02.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€75.00
21.01.24
-
21.01.25
-2.67%
03.02.24

Could be worthwhile Investment >10% per year